ClearPoint Neuro, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 161.18K shares, a 2586.32% increase year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 50.69K shares, a 325.77% increase year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 19.11K shares, a 169.49% increase year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 1.00K shares, a 0.00% change year-over-year.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 38.01K shares, a 99.13% increase from fiscal 2024.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 19.09K shares, a 4.55% decline from fiscal 2023.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 20.00K shares, a 33.33% decline from fiscal 2022.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 30.00K shares, a 94.68% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 161.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | 231.98K shares derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 50.69K shares 10-Q · filed 2026-05-13 | 76.80K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 19.11K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 38.01K shares 10-K · filed 2026-03-17 |
| 2025-09-30 | 1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 26.00K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 6.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 26.00K shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 11.91K shares 10-Q · filed 2025-05-13 | 23.50K shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 7.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 19.09K shares 10-K · filed 2025-02-26 |
| 2024-09-30 | 1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 12.00K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 3.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | |
| 2024-03-31 | 7.50K shares 10-Q · filed 2024-05-07 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 20.00K shares 10-K · filed 2024-03-12 |
| 2022-12-31 | 1.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 30.00K shares 10-K · filed 2023-03-01 |
| 2022-09-30 | 28.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 35.29K shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | 116.58K shares derived: sum of 4 quarters · filed 2022-08-10 |
| 2022-03-31 | 1.00K shares 10-Q · filed 2022-05-11 | 147.58K shares derived: sum of 4 quarters · filed 2022-05-11 |
| 2021-12-31 | 6.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | 563.48K shares 10-K · filed 2022-03-09 |
| 2021-09-30 | 109.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 587.31K shares derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | 31.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 478.02K shares derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | 416.90K shares 10-Q · filed 2021-05-11 | |
| 2020-12-31 | 30.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | 30.96K shares 10-K · filed 2021-03-22 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | |
| 2019-12-31 | 525.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | 3.02K shares 10-K · filed 2021-03-22 |
| 2014-12-31 | -325.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -162.50K shares 10-K · filed 2016-03-25 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | |
| 2014-03-31 | 162.50K shares 10-Q · filed 2014-05-13 | |
| 2012-12-31 | -16.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | 14.00K shares 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |